Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial. [electronic resource]
Producer: 20200624Description: 2968-2973 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Double-Blind Method
- Female
- Humans
- Indazoles -- administration & dosage
- Maintenance Chemotherapy
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Organoplatinum Compounds -- administration & dosage
- Ovarian Neoplasms -- drug therapy
- Piperidines -- administration & dosage
- Poly(ADP-ribose) Polymerase Inhibitors -- administration & dosage
- Progression-Free Survival
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.